Tolerability Clinical Trial
Official title:
A Phase I Study of Orally-administered AZD5213 in Healthy Males and Non-fertile Females Including Randomized, Double-blind, Placebo-controlled, Parallel-group Assessment of the Safety, Tolerability & PK of Single Ascending Dose (Part 1) & an Open-label Assessment of Effect of Food on the PK (Part 2)
1. The main purpose of this study is to assess the safety and tolerability of AZD5213
after single oral doses.
2. Another purpose of this study is to evaluate the pharmacokinetics (also called PK - how
the study drug enters and leaves your body and how your body acts on the study drug) of
AZD5213 in your blood and urine.
One group of subjects will be studied to see how food affects the pharmacokinetics (PK) of
AZD5213 in the blood and urine. They will receive AZD5213 once after fasting overnight and
then return to the clinic to receive AZD5213 after eating a high fat breakfast.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04693429 -
Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+
|
Phase 1 | |
| Active, not recruiting |
NCT01703871 -
Music During Diagnostic Hysteroscopy
|
N/A | |
| Completed |
NCT01260025 -
Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid Tumor
|
Phase 1 | |
| Not yet recruiting |
NCT00944268 -
Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety
|
Phase 3 | |
| Completed |
NCT01959685 -
A Dose Escalating Study to Determine the Tolerability and PK of a Single Dose of Androxal
|
Phase 1 | |
| Completed |
NCT01841801 -
Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches
|
N/A | |
| Completed |
NCT01841788 -
Evaluation of Experimental Heat Patch
|
N/A | |
| Completed |
NCT01158755 -
Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study
|
Phase 2 | |
| Completed |
NCT05633147 -
Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam
|
Phase 1 | |
| Completed |
NCT01981928 -
A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans
|
Phase 1 | |
| Completed |
NCT01954589 -
Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206
|
Phase 1 | |
| Completed |
NCT01023282 -
Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients
|
Phase 1 | |
| Completed |
NCT02512575 -
A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.
|
Phase 1 | |
| Recruiting |
NCT05142592 -
IPG7236 in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT05044949 -
Study Evaluating the Safety and Tolerability of a Probioitc
|
N/A | |
| Completed |
NCT05795192 -
SB17170 Phase1 Trial in Healthy Volunteer
|
Phase 1 | |
| Completed |
NCT05847218 -
Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers
|
Phase 1 | |
| Terminated |
NCT03503968 -
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms
|
Phase 1/Phase 2 | |
| Completed |
NCT02107885 -
Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.
|
Phase 1 | |
| Withdrawn |
NCT01086813 -
Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043
|
Phase 1 |